Firefly Neuroscience
AIFF
17 hedge funds and large institutions have $192K invested in Firefly Neuroscience in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0.03% more ownership
Funds ownership: 0.09% → 0.12% (+0.03%)
0% more funds holding
Funds holding: 17 → 17 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
22% less capital invested
Capital invested by funds: $248K → $192K (-$55.5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$64.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$32.3K |
| 3 |
VF
Virtu Financial
New York
|
+$28.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$13K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$18.7K |
| 2 |
Renaissance Technologies
New York
|
-$15K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$9.48K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8.99K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$8 |
AIFF Hedge Fund Activity: Q1 2023 in Review
17 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Firefly Neuroscience (AIFF) for Q1 2023, worth a combined $192K — down 22% from $248K a quarter earlier.
Fund positioning in AIFF was balanced in Q1 2023: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Pathstone Family Office, opening a new position worth an estimated $64.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $18.7K sold.
- 17 institutional investors held Firefly Neuroscience (AIFF) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $192K of Firefly Neuroscience stock for Q1 2023, down 22% quarter-over-quarter.
- 3 funds opened new Firefly Neuroscience positions in Q1 2023 and 3 closed out, a net change of 0 holders.
- The largest Firefly Neuroscience buyer in Q1 2023 was Pathstone Family Office, an estimated $64.8K added.
- The largest Firefly Neuroscience seller in Q1 2023 was Citadel Advisors, an estimated $18.7K sold.
Based on aggregated 13F filings for Q1 2023.